Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Nabel

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
Human Gene Therapy|March 12, 2005
Adenovirus vector-based vaccines for human immunodeficiency virus type 1Dan H Barouch, Gary J Nabel
Science Translational Medicine|April 19, 2016
Once and future epidemics: Zika virus emergingGary J Nabel, Elias A Zerhouni
Nature|December 22, 2018
All for one and one for all to fight fluGary J Nabel, John W Shiver
Nature Medicine|December 8, 2010
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccineGary J Nabel, Anthony S Fauci
Immunological Reviews|January 5, 2011
VaccinesDaniel C Douek, Gary J Nabel
Science (New York, N.Y.)|June 6, 2020
Patents, economics, and pandemicsWill Zerhouni, Gary J Nabel, Elias Zerhouni
Journal of Virology|August 28, 2003
Ebola virus pathogenesis: implications for vaccines and therapiesNancy Sullivan, Zhi-Yong Yang, Gary J Nabel
Journal of Virology|June 16, 2005
Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogensLan Wu, Wing-Pui Kong, Gary J Nabel
Journal of Virology|December 15, 2004
Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccineWataru Akahata, Zhi-yong Yang, Gary J Nabel
Molecular Cell|August 23, 2002
The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoproteinYue Huang, Ling Xu, Yongnian Sun, et al.
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
Human Gene Therapy|March 12, 2005
Adenovirus vector-based vaccines for human immunodeficiency virus type 1Dan H Barouch, Gary J Nabel
Science Translational Medicine|April 19, 2016
Once and future epidemics: Zika virus emergingGary J Nabel, Elias A Zerhouni
Nature|December 22, 2018
All for one and one for all to fight fluGary J Nabel, John W Shiver
Nature Medicine|December 8, 2010
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccineGary J Nabel, Anthony S Fauci
Immunological Reviews|January 5, 2011
VaccinesDaniel C Douek, Gary J Nabel
Science (New York, N.Y.)|June 6, 2020
Patents, economics, and pandemicsWill Zerhouni, Gary J Nabel, Elias Zerhouni
Journal of Virology|August 28, 2003
Ebola virus pathogenesis: implications for vaccines and therapiesNancy Sullivan, Zhi-Yong Yang, Gary J Nabel
Journal of Virology|June 16, 2005
Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogensLan Wu, Wing-Pui Kong, Gary J Nabel
Journal of Virology|December 15, 2004
Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccineWataru Akahata, Zhi-yong Yang, Gary J Nabel
Molecular Cell|August 23, 2002
The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoproteinYue Huang, Ling Xu, Yongnian Sun, et al.
Pageof 25